Scientists at the University of Liverpool are leading a
£1.65 million project to produce and test the first nanomedicines for treating
HIV/AIDS.
The research project, funded by the Engineering and Physical
Sciences Research Council (EPSRC), aims to produce cheaper, more effective
medicines which have fewer side effects and are easier to give to newborns and
children.